GSA Capital Partners’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | – | Sell |
-3,511
| Closed | -$359K | – | 1480 |
|
2020
Q2 | $359K | Buy |
+3,511
| New | +$359K | 0.2% | 131 |
|
2020
Q1 | – | Sell |
-2,500
| Closed | -$291K | – | 1790 |
|
2019
Q4 | $291K | Hold |
2,500
| – | – | 0.03% | 1051 |
|
2019
Q3 | $286K | Buy |
+2,500
| New | +$286K | 0.04% | 934 |
|
2018
Q3 | – | Sell |
-15,900
| Closed | -$1.58M | – | 2085 |
|
2018
Q2 | $1.58M | Sell |
15,900
-13,010
| -45% | -$1.29M | 0.08% | 418 |
|
2018
Q1 | $2.34M | Buy |
28,910
+710
| +3% | +$57.5K | 0.12% | 206 |
|
2017
Q4 | $2.22M | Buy |
28,200
+15,285
| +118% | +$1.2M | 0.14% | 193 |
|
2017
Q3 | $1.19M | Sell |
12,915
-1,600
| -11% | -$148K | 0.08% | 405 |
|
2017
Q2 | $1.64M | Buy |
14,515
+12,300
| +555% | +$1.39M | 0.11% | 239 |
|
2017
Q1 | $222K | Sell |
2,215
-21,622
| -91% | -$2.17M | 0.01% | 1521 |
|
2016
Q4 | $2.56M | Sell |
23,837
-5,084
| -18% | -$547K | 0.15% | 132 |
|
2016
Q3 | $3.6M | Sell |
28,921
-12,894
| -31% | -$1.61M | 0.19% | 66 |
|
2016
Q2 | $4.45M | Buy |
41,815
+1,320
| +3% | +$140K | 0.25% | 25 |
|
2016
Q1 | $4.64M | Sell |
40,495
-2,799
| -6% | -$320K | 0.3% | 12 |
|
2015
Q4 | $6.17M | Sell |
43,294
-7,621
| -15% | -$1.09M | 0.3% | 15 |
|
2015
Q3 | $4.57M | Buy |
50,915
+12,000
| +31% | +$1.08M | 0.22% | 51 |
|
2015
Q2 | $4.48M | Buy |
38,915
+2,200
| +6% | +$253K | 0.17% | 68 |
|
2015
Q1 | $3.51M | Buy |
36,715
+14,200
| +63% | +$1.36M | 0.14% | 113 |
|
2014
Q4 | $1.51M | Buy |
22,515
+400
| +2% | +$26.9K | 0.11% | 241 |
|
2014
Q3 | $1.19M | Buy |
22,115
+7,700
| +53% | +$415K | 0.06% | 389 |
|
2014
Q2 | $641K | Buy |
14,415
+8,522
| +145% | +$379K | 0.03% | 973 |
|
2014
Q1 | $204K | Sell |
5,893
-11,400
| -66% | -$395K | 0.01% | 1380 |
|
2013
Q4 | $499K | Sell |
17,293
-10,600
| -38% | -$306K | 0.04% | 845 |
|
2013
Q3 | $815K | Buy |
27,893
+2,800
| +11% | +$81.8K | 0.06% | 467 |
|
2013
Q2 | $582K | Buy |
+25,093
| New | +$582K | 0.07% | 462 |
|